Emollient satisfaction questionnaire: validation study in children with eczema.


Journal

Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847

Informations de publication

Date de publication:
Jul 2022
Historique:
revised: 27 02 2022
received: 11 10 2021
accepted: 18 03 2022
pubmed: 23 3 2022
medline: 2 7 2022
entrez: 22 3 2022
Statut: ppublish

Résumé

Emollients are used as maintenance therapy for all severities of eczema but there is a lack of head-to-head comparisons of effectiveness and acceptability. To determine the validity of a self-report questionnaire designed to assess user satisfaction with a given emollient and to report the findings. Data were analysed from the Choice of Moisturiser for Eczema Treatment trial, which compared four emollient types (Aveeno Data from 77.2% (152 of 197) of participants were analysed. One item was rejected because of a high rate (44.7%) of 'don't know' responses, leaving seven items with high completion rates (98.7%) and weak evidence of floor or ceiling effects. A positive association was observed between total score and overall emollient satisfaction (Spearman correlation 0.78; P < 0.001). Total scores were highest (mean ± SD 23.5 ± 3.9) in the lotion group and lowest (18.4 ± 4.6) in the ointment group. The emollient satisfaction questionnaire appears to have good validity. Further work is required to validate the questionnaire in other settings and to assess its reliability.

Sections du résumé

BACKGROUND BACKGROUND
Emollients are used as maintenance therapy for all severities of eczema but there is a lack of head-to-head comparisons of effectiveness and acceptability.
AIM OBJECTIVE
To determine the validity of a self-report questionnaire designed to assess user satisfaction with a given emollient and to report the findings.
METHODS METHODS
Data were analysed from the Choice of Moisturiser for Eczema Treatment trial, which compared four emollient types (Aveeno
RESULTS RESULTS
Data from 77.2% (152 of 197) of participants were analysed. One item was rejected because of a high rate (44.7%) of 'don't know' responses, leaving seven items with high completion rates (98.7%) and weak evidence of floor or ceiling effects. A positive association was observed between total score and overall emollient satisfaction (Spearman correlation 0.78; P < 0.001). Total scores were highest (mean ± SD 23.5 ± 3.9) in the lotion group and lowest (18.4 ± 4.6) in the ointment group.
CONCLUSION CONCLUSIONS
The emollient satisfaction questionnaire appears to have good validity. Further work is required to validate the questionnaire in other settings and to assess its reliability.

Identifiants

pubmed: 35315540
doi: 10.1111/ced.15189
pmc: PMC9321994
doi:

Substances chimiques

Emollients 0
Ointments 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1337-1345

Informations de copyright

© 2022 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

Références

J Pers Assess. 2003 Feb;80(1):99-103
pubmed: 12584072
Br J Dermatol. 1998 Jul;139(1):73-6
pubmed: 9764151
Ann Dermatol. 2014 Aug;26(4):528-31
pubmed: 25143690
Pediatr Dermatol. 2019 Jan;36(1):36-65
pubmed: 30303557
BMJ Open. 2019 Nov 6;9(11):e033387
pubmed: 31699751
J Dermatol. 2011 Jun;38(6):531-5
pubmed: 21352299
Trials. 2015 Jul 15;16:304
pubmed: 26170126
Br J Gen Pract. 2012 Apr;62(597):e261-7
pubmed: 22520913
J Dermatolog Treat. 2020 Dec;31(8):801-809
pubmed: 31631717
JB JS Open Access. 2019 Dec 05;4(4):
pubmed: 32043052
J Clin Epidemiol. 2018 Nov;103:71-81
pubmed: 30031210
BMJ Open. 2016 Nov 16;6(11):e012021
pubmed: 27852708
BMJ. 2019 Oct 24;367:l5882
pubmed: 31649114
Cochrane Database Syst Rev. 2017 Feb 06;2:CD012119
pubmed: 28166390

Auteurs

Georgia G Rowley (GG)

Population Health Sciences, Bristol Medical School, Bristol, UK.

Stephanie J MacNeill (SJ)

Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK.

Matthew J Ridd (MJ)

Population Health Sciences, Bristol Medical School, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH